10 studies: showed a reduced risk of any fracture vs VKAs (RR = 0.80; 95% CI: 0.70–0.91)👨🏻 (RR = 0.79; 95% CI: 0.67–0.92) 👩🏻🦰 (RR = 0.71; 95% CI: 0.57–0.89)]. Api (RR = 0.75; 95% CI: 0.60–0.92) and riva (RR = 0.73; 95% CI: 0.61–0.88) https://t.co/u6oUACG0
RT @FrontCVMedicine: New Research: Association of Direct Oral Anticoagulants vs. Vitamin K Antagonists With Fractures in Atrial Fibrillatio…
New Research: Association of Direct Oral Anticoagulants vs. Vitamin K Antagonists With Fractures in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis: Background: Current evidence regarding the application of direct oral… https://t.co/GyR